Yuan-Ching P. Chiang
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yuan-Ching P. Chiang.
Tetrahedron Letters | 1991
Kathryn L. Thompson; Michael N. Chang; Yuan-Ching P. Chiang; Shu Shu Yang; John C. Chabala; Byron H. Arison; Michael D. Greenspan; Darlene P. Hanf; Joel B. Yudkovitz
Abstract A series of δ-lactone ( 1 and 2 ), oxetane ( 3 ) and azetidinone ( 4 and 5 ) analogs were prepared from the HMG CoA synthase inhibitor L-659,699 ((E,E)-11-[3′R-(hydroxymethyl)-4′-oxo-2′R-oxetanyl]-3,5,7R- trimethyl-2,4-undecadienoic acid 1,2 ), which maintained the trans relationship of the ring side chains. The N-tosyl azetidinone analog represents the first reported member of a new series of non β-lactone HMG CoA synthase inhibitors.
Archive | 1991
John C. Chabala; Michael N. Chang; Yuan-Ching P. Chiang; James V. Heck; Kathryn L. Thompson; Shu S. Yang
Archive | 1989
Shu Shu Yang; Yuan-Ching P. Chiang; James V. Heck; Michael N. Chang
Archive | 1988
John C. Chabala; Yuan-Ching P. Chiang; Michael N. Chang; Donald W. Graham; James V. Heck; Shu S. Yang
Archive | 1993
Yuan-Ching P. Chiang; Tesfaye Biftu
Archive | 1987
Yuan-Ching P. Chiang; Tesfaye Biftu; Donald W. Graham; Shu Shu Yang; Michael N. Chang; John C. Chabala; Kathryn L. Thomson
Archive | 1987
John C. Chabala; Yuan-Ching P. Chiang; Michael N. Chang; Narindar M. Girotra; Donald W. Graham; Shu S. Yang
Archive | 1989
Michael N. Chang; Yuan-Ching P. Chiang; James V. Heck; Michael D. Lewis; Shu S. Yang
Archive | 1991
Michael N. Chang; Yuan-Ching P. Chiang; James V. Heck; Michael D. Lewis
Archive | 1992
John J. Acton; Gregory D. Berger; James D. Bergstrom; Tesfaye Biftu; Robert L. Bugianesi; Robert M. Burk; Yuan-Ching P. Chiang; Claude Dufresne; N.N. Girotra; Chan-Hwa Kuo; Robert W. Marquis; William H. Parsons; Sandra P. Plevyak; Mitree M. Ponpipom; Conrad Santini; Lori L Whiting